BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 17605470)

  • 1. Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective.
    Järås K; Ressine A; Nilsson E; Malm J; Marko-Varga G; Lilja H; Laurell T
    Anal Chem; 2007 Aug; 79(15):5817-25. PubMed ID: 17605470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology.
    Huhtinen P; Soukka T; Lövgren T; Härmä H
    J Immunol Methods; 2004 Nov; 294(1-2):111-22. PubMed ID: 15604021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ENSAM: Europium Nanoparticles for Signal enhancement of Antibody Microarrays on nanoporous silicon.
    Järås K; Tajudin AA; Ressine A; Soukka T; Marko-Varga G; Bjartell A; Malm J; Laurell T; Lilja H
    J Proteome Res; 2008 Mar; 7(3):1308-14. PubMed ID: 18257515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cancer protein microarray platform using antibody fragments and its clinical applications.
    Song S; Li B; Wang L; Wu H; Hu J; Li M; Fan C
    Mol Biosyst; 2007 Feb; 3(2):151-8. PubMed ID: 17245494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
    Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V
    J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acoustic whole blood plasmapheresis chip for prostate specific antigen microarray diagnostics.
    Lenshof A; Ahmad-Tajudin A; Järås K; Swärd-Nilsson AM; Aberg L; Marko-Varga G; Malm J; Lilja H; Laurell T
    Anal Chem; 2009 Aug; 81(15):6030-7. PubMed ID: 19594154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive adenovirus immunoassay as a model for using nanoparticle label technology in virus diagnostics.
    Valanne A; Huopalahti S; Soukka T; Vainionpää R; Lövgren T; Härmä H
    J Clin Virol; 2005 Jul; 33(3):217-23. PubMed ID: 15911443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Femtomolar detection of prostate-specific antigen: an immunoassay based on surface-enhanced Raman scattering and immunogold labels.
    Grubisha DS; Lipert RJ; Park HY; Driskell J; Porter MD
    Anal Chem; 2003 Nov; 75(21):5936-43. PubMed ID: 14588035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneous dual-parameter assay for prostate-specific antigen based on fluorescence resonance energy transfer.
    Kokko T; Liljenbäck T; Peltola MT; Kokko L; Soukka T
    Anal Chem; 2008 Dec; 80(24):9763-8. PubMed ID: 19012418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macro-/nanoporous silicon as a support for high-performance protein microarrays.
    Ressine A; Ekström S; Marko-Varga G; Laurell T
    Anal Chem; 2003 Dec; 75(24):6968-74. PubMed ID: 14670060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface plasmon fluorescence immunoassay of free prostate-specific antigen in human plasma at the femtomolar level.
    Yu F; Persson B; Löfås S; Knoll W
    Anal Chem; 2004 Nov; 76(22):6765-70. PubMed ID: 15538801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved porous silicon microarray based prostate specific antigen immunoassay by optimized surface density of the capture antibody.
    Lee S; Kim S; Malm J; Jeong OC; Lilja H; Laurell T
    Anal Chim Acta; 2013 Sep; 796():108-14. PubMed ID: 24016590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of protein analytes via nanoparticle-based bio bar code technology.
    Bao YP; Wei TF; Lefebvre PA; An H; He L; Kunkel GT; Müller UR
    Anal Chem; 2006 Mar; 78(6):2055-9. PubMed ID: 16536446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porous silicon surfaces: a candidate substrate for reverse protein arrays in cancer biomarker detection.
    Ressine A; Corin I; Järås K; Guanti G; Simone C; Marko-Varga G; Laurell T
    Electrophoresis; 2007 Dec; 28(23):4407-15. PubMed ID: 18041036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplexed sandwich assays in microarray format.
    Nielsen UB; Geierstanger BH
    J Immunol Methods; 2004 Jul; 290(1-2):107-20. PubMed ID: 15261575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of ultra-high sensitivity bioluminescent enzyme immunoassay for prostate-specific antigen (PSA) using firefly luciferase.
    Seto Y; Iba T; Abe K
    Luminescence; 2001; 16(4):285-90. PubMed ID: 11512145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody microarrays for native toxin detection.
    Rucker VC; Havenstrite KL; Herr AE
    Anal Biochem; 2005 Apr; 339(2):262-70. PubMed ID: 15797567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nanoparticle label/immunochromatographic electrochemical biosensor for rapid and sensitive detection of prostate-specific antigen.
    Lin YY; Wang J; Liu G; Wu H; Wai CM; Lin Y
    Biosens Bioelectron; 2008 Jun; 23(11):1659-65. PubMed ID: 18406127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence.
    Härmä H; Soukka T; Lönnberg S; Paukkunen J; Tarkkinen P; Lövgren T
    Luminescence; 2000; 15(6):351-5. PubMed ID: 11114110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.